Episode Details
Back to Episodes
First Nasal Spray for PSVT Approved | Charlotte News
Description
Big news from Charlotte: Milestone Pharmaceuticals just got FDA approval for Cardamyst, the first-ever self-administered nasal spray treatment for adults with paroxysmal supraventricular tachycardia (PSVT). Approved in December 2025, this breakthrough offers a simple, at-home solution to restore normal heart rhythm during episodes — a major leap after decades without new options. Developed right here in Charlotte, Cardamyst could transform how patients manage cardiac events outside the hospital, making it a game-changer in accessible heart care.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/94910facf64fecec